Dextran 75 and Moxetumomab pasudotox
Determining the interaction of Dextran 75 and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextran, high molecular weight
Brand name: Dextran 70 6% in 5% Dextrose, Hyskon, Macrodex, Gentran 70, Dextran-HM, Dextran 70 6% in 09% Sodium Chloride
Synonyms: Dextran (high molecular weight)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextran 75-Moxetumomab Pasudotox-tdfk
- Dextran 75-Moxetumomab pasudotox-tdfk Intravenous
- Dextran 75-Moxifloxacin
- Dextran 75-Moxifloxacin (Systemic)
- Dextran 75-Moxifloxacin Hydrochloride
- Dextran 75-Moxifloxacin Injection
- Moxetumomab pasudotox-Dextran high molecular weight
- Moxetumomab pasudotox-Dextranomer and Hyaluronate Derivatives (Deflux)
- Moxetumomab pasudotox-Dextranomer and Hyaluronate Derivatives (Solesta)
- Moxetumomab pasudotox-Dextranomer and sodium hyaluronate
- Moxetumomab pasudotox-Dextroamphetamine
- Moxetumomab pasudotox-Dextroamphetamine and amphetamine